[Trial Data] nausea rates in the combination arm vs sema alone
nausea rates in the combination arm vs sema alone — a position I have arrived at slowly and would like tested. Went looking for independent results on this and found a handful across the whole site. That is the honest state of the evidence. Asked a question here that turned out to be based on a mechanism confusion.…
Bought small deliberately because the evidence base is thin. That felt like the only defensible approach.
That result is preclinical. Worth flagging, since the thread has been reading it as human data.
long-acting amylin is the whole point of the molecule
That result is preclinical.
Disagreeing with this line: that figure is from a combination arm and is being quoted as monotherapy.
REDEFINE is the combination programme
amylin analogue, different receptor family, different story